Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Cutaneous sarcoidosis.

N J Wilson1, C M King

  • 1Department of Dermatology, Royal Liverpool University Hospital, UK.

Postgraduate Medical Journal
|April 10, 1999
PubMed
Summary
This summary is machine-generated.

Sarcoidosis is a multisystem granulomatous disease. Cutaneous sarcoidosis, affecting 25% of patients, requires biopsy for diagnosis and prognosis depends on systemic involvement.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Australian Registered Nurse's' Awareness of Key Issues, Ambivalence and Education Related to the Health of People With Intellectual Disability and/or Autism.

Journal of applied research in intellectual disabilities : JARID·2025
Same author

Patient experiences during the planned perioperative care pathway: An integrative review.

Journal of advanced nursing·2024
Same author

Training support workers about the overmedication of people with intellectual disabilities: an Australian pre-post pilot study.

Journal of intellectual disability research : JIDR·2023
Same author

Access to Sexual Health Services and Support for People with Intellectual and Developmental Disabilities: an Australian Cross-sector Survey.

Sexuality research & social policy : journal of NSRC : SR & SP·2022
Same author

Novel mutations in desmoglein 1: focal palmoplantar keratoderma in milder phenotypes.

The British journal of dermatology·2019
Same author

Painful punctate palmoplantar keratoderma due to heterozygous mutations in AAGAB.

The British journal of dermatology·2018
Same journal

Comparative efficacy of Janus kinase inhibitors in severe alopecia areata: a network meta-analysis based on randomized controlled trials.

Postgraduate medical journal·2026
Same journal

Two cases of toxic epidermal necrolysis with severe ocular involvement treated with adjunctive tofacitinib.

Postgraduate medical journal·2026
Same journal

Diastolic dysfunction and diabetes: the DIADAD study-a retrospective cohort study from Liverpool.

Postgraduate medical journal·2026
Same journal

Care, cash, and proof: forensic accountability for war-related starvation.

Postgraduate medical journal·2026
Same journal

Response to traumatic injuries in polo players in England.

Postgraduate medical journal·2026
Same journal

Aids to venesection and parenteral drug administration in patients with difficult veins.

Postgraduate medical journal·2026
See all related articles

Area of Science:

  • Dermatology
  • Immunology
  • Pathology

Background:

  • Sarcoidosis is a multisystem granulomatous disorder of unknown etiology.
  • Cutaneous sarcoidosis affects approximately 25% of patients with systemic sarcoidosis and can also present as an isolated condition.
  • The clinical manifestations of skin sarcoidosis are diverse.

Purpose of the Study:

  • To outline the diagnostic criteria for cutaneous sarcoidosis.
  • To discuss the prognostic factors influencing the management of skin sarcoidosis.
  • To highlight treatment considerations for aggressive cutaneous sarcoidosis.

Main Methods:

  • Diagnosis is confirmed by skin biopsy demonstrating non-caseating granulomas.
  • Differential diagnosis involves excluding other granulomatous skin conditions.

Related Experiment Videos

  • Prognosis and treatment are guided by the extent of systemic disease involvement.

    • Main Results:

    • Non-caseating granulomas on skin biopsy are diagnostic hallmarks.
    • Systemic involvement significantly impacts the prognosis of cutaneous sarcoidosis.
    • Aggressive, skin-limited disease may necessitate immunosuppressive therapies.

    Conclusions:

    • Cutaneous sarcoidosis diagnosis relies on histopathological findings and exclusion of mimics.
    • Management strategies for skin sarcoidosis are dictated by systemic disease activity.
    • Immunosuppression is a therapeutic option for severe, localized cutaneous sarcoidosis.